Top compounds associated with response to LYPD2


Feature Type Standardized
Nominal ANOVA
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.06 0.07
mRNA I-BET-762 GDSC1000 pan-cancer AAC -0.05 0.07
mRNA Crizotinib gCSI pan-cancer AAC -0.11 0.07
mRNA SB590885 GDSC1000 pan-cancer AAC -0.058 0.07
mRNA SL 0101-1 GDSC1000 pan-cancer AAC -0.065 0.08
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.061 0.08
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.24 0.08
mRNA avicin D CTRPv2 pan-cancer AAC 0.095 0.08
mRNA QL-XII-61 GDSC1000 pan-cancer AAC -0.098 0.08
mRNA TPCA-1 GDSC1000 pan-cancer AAC -0.05 0.08
Download CSV